Literature DB >> 30657586

Zyxin: a mechanotransductor to regulate gene expression.

Y-X Wang1, D-Y Wang, Y-C Guo, J Guo.   

Abstract

OBJECTIVE: Cells answer to biochemical, electrical and mechanical signals in the environment, which regulate their behavior. Mechanical signals can propagate through mechanically stiff structures like focal adhesions (FAs). Zyxin, a LIM domain protein, is localized primarily at focal adhesion plaques. Growing evidence suggests that zyxin is a vital mechanotransductor to regulate the gene expression. In this review, we summarize the features of zyxin and the molecular mechanism of how zyxin participate in the cellular activity.
MATERIALS AND METHODS: An English-language literature search is based on a keyword-based query of multiple databases (MEDLINE, Embase) and bibliographies from identified publications. The references in the selected paper are also considered as an additional source of data. The search was last updated in April 2018; no limitations are applied.
RESULTS: Zyxin enhances actin polymerization with the aid of Enabled (Ena)/vasodilator-stimulated phosphoprotein (VASP) proteins in response to mechanical tension, to perform its role in stress fibers (SFs) remodeling and repair. Zyxin can translocate from focal adhesions (FAs) to the nucleus responds to stretch, and regulate gene transcription by interaction with transcription factors like nuclear matrix protein 4 (NMP4). Misregulation of nuclear functions of zyxin appears to be associated with pathogenic effects and diseases, such as prostate cancer and non-small-cell lung cancer.
CONCLUSIONS: Zyxin is a crucial ingredient of the cellular mechanotransducing system and can modulate the gene expression. Given its clinical relevance, zyxin is also a promising target for the diagnosis and treatment of certain diseases. Understanding the role of zyxin in force sensing and gene expression regulating provides a compelling challenge for future biomechanics studies, and offers attractive evidence for zyxin as a potential diagnostic marker and therapeutic target for clinical diseases.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30657586     DOI: 10.26355/eurrev_201901_16790

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  7 in total

Review 1.  Manipulation of Focal Adhesion Signaling by Pathogenic Microbes.

Authors:  Korinn N Murphy; Amanda J Brinkworth
Journal:  Int J Mol Sci       Date:  2021-01-29       Impact factor: 5.923

2.  Arterial cyclic stretch regulates Lamtor1 and promotes neointimal hyperplasia via circSlc8a1/miR-20a-5p axis in vein grafts.

Authors:  Ji-Ting Liu; Qing-Ping Yao; Yi Chen; Fan Lv; Ze Liu; Han Bao; Yue Han; Ming-Liang Zhang; Zong-Lai Jiang; Ying-Xin Qi
Journal:  Theranostics       Date:  2022-06-21       Impact factor: 11.600

Review 3.  Functional Remodeling of the Contractile Smooth Muscle Cell Cortex, a Provocative Concept, Supported by Direct Visualization of Cortical Remodeling.

Authors:  Worawit Suphamungmee; William Lehman; Kathleen G Morgan
Journal:  Biology (Basel)       Date:  2022-04-26

4.  Cell density-dependent proteolysis by HtrA1 induces translocation of zyxin to the nucleus and increased cell survival.

Authors:  Fabio Sabino; Elizabeta Madzharova; Ulrich Auf dem Keller
Journal:  Cell Death Dis       Date:  2020-08-21       Impact factor: 8.469

Review 5.  Shuttling of cellular proteins between the plasma membrane and nucleus (Review).

Authors:  Hua-Chuan Zheng; Hua-Mao Jiang
Journal:  Mol Med Rep       Date:  2021-11-15       Impact factor: 2.952

6.  Clinical Significance of Detection of Peripheral Blood VASP Level in Lung Cancer Patients.

Authors:  Jin Ma; Shumin Zhu; Zhiqing Chen; Xinyuan Li; Yafei Mao; Xin Tian; Li Zhao; Yanming Li; Baoqin Li; Yulan Geng
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-31       Impact factor: 2.650

7.  A Personalized Genomics Approach of the Prostate Cancer.

Authors:  Sanda Iacobas; Dumitru A Iacobas
Journal:  Cells       Date:  2021-06-30       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.